Clinical study of minimally invasive punctural evacuation in the treatment of basal ganglion region cerebral hemorrhage
10.3760/cma.j.issn.1673-4904.2012.11.009
- VernacularTitle:微创穿刺清除术在基底节区脑出血治疗中的临床应用研究
- Author:
Chuan LU
;
Jianhu LIN
;
Huajun BA
;
Xiandong CHEN
;
Maohua CHEN
;
Jun SUN
- Publication Type:Journal Article
- Keywords:
Cerebral hemorrhage;
Surgical procedures,minimally invasive;
Prognosis
- From:
Chinese Journal of Postgraduates of Medicine
2012;35(11):25-27
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo study the clinical effect of YL-1 type hematoma puncture needle in the treatment of basal ganglion region cerebral hemorrhage.MethodsSixty-two patients with hypertensive basal ganglion region cerebral hemorrhage were treated by YL-1 type hematoma puncture needle from January 2007 to May 2011 (minimally invasive punctural evacuation group),of which,60 patients were treated by conservative treatment(conservative treatment group) as control,compared two groups of neural function defect score,hematoma clearance rate on admission,after 3 weeks treatment,and quality of life after 6 months.ResultsNeural function defect score on admission of minimally invasive punctural evacuation group was (23.6 ± 18.4) scores,while (23.4 ± 17.8) scores in conservative treatment group,the difference was not statistically significant(P ＞ 0.05).After 3 weeks' treatment,neural function defect score and hematoma clearance rate of minimally invasive punctural evacuation group was superior to conservative treatment group [ (14.6 ± 12.4) scores vs.(20.1 ± 18.4) scores,(92.3 ± 5.4)％ vs.(79.5 ± 13.8)％ ] (P ＜0.05 ).After 6 months' treatment,the good rate of quality of life in minimally invasive punctural evacuation group was 81.7％(49/60),which was significantly increased compared with that of conservative treatment group [67.2％ (39/58)] (P ＜ 0.05).ConclusionsThe minimally invasive punctural evacuation in the treatment of basal ganglion region cerebral hemorrhage has small invasion,better prognosis,effective and fast decompression of intracranial hematoma,reducing disability rates,improvement of the quality of life,which could be a beneficial complement for traditional therapies.
